Power high-purity proteomics at scale
Mass spec workflows demand clean, cell-type-specific inputs. QCPRECISE™ delivers tumor-enriched protein extractions at high throughput, enabling proteomics analysis that’s as scalable as it is precise.
Speed up the development of targeted therapies
Cleaner input means better output. With increased sample purity and enriched nucleic acids and proteins, QCPRECISE™ improves the reliability of downstream assays—accelerating timelines for biomarker validation and therapeutic development.
Recruit the right patients, faster
Our high-purity samples increase signal-to-noise and reduce inconclusive results—enabling faster, more confident identification of eligible patients for biomarker-driven trials, and useful results even from small patient cohorts.
Discover biomarkers others can’t see
By combining digital pathology with sub-50µm tissue targeting, we enable spatially resolved tumor-specific analysis—even in dispersed or mixed cellular environments—driving novel biomarker discovery from challenging samples.